Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
about
Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?[Advance directive of probands in pharmaceutical research : A medical ethics discussion].Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorderQ58775162Optimizing medications in older adults with cognitive impairment: Considerations for primary care clinicians
P2860
Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipsychotic use in dementia: ...... s and risks from meta-analyses
@en
Antipsychotic use in dementia: ...... and risks from meta-analyses.
@nl
type
label
Antipsychotic use in dementia: ...... s and risks from meta-analyses
@en
Antipsychotic use in dementia: ...... and risks from meta-analyses.
@nl
prefLabel
Antipsychotic use in dementia: ...... s and risks from meta-analyses
@en
Antipsychotic use in dementia: ...... and risks from meta-analyses.
@nl
P2093
P2860
P356
P1476
Antipsychotic use in dementia: ...... s and risks from meta-analyses
@en
P2093
Deena J Tampi
Rajesh R Tampi
Shilpa Srinivasan
Silpa Balachandran
P2860
P304
P356
10.1177/2040622316658463
P577
2016-07-15T00:00:00Z